Automated description from the Alliance of Genome Resources (Release 9.0.0)
Predicted to enable A2-type glycerophospholipase activity; calcium ion binding activity; and phospholipid binding activity. Predicted to be involved in negative regulation of T cell proliferation; phosphatidylcholine metabolic process; and phosphatidylglycerol metabolic process. Is expressed in several structures, including liver; lung; primary palate; small intestine; and spleen. Human ortholog(s) of this gene implicated in cholecystolithiasis; colorectal cancer; gastroesophageal reflux disease; and human immunodeficiency virus infectious disease. Orthologous to human PLA2G2A (phospholipase A2 group IIA).
This site uses cookies.
Some cookies are essential for site operations and others help us analyze use and utility of our web site.
Please refer to our
privacy policy
for more information.